手术治疗胃肠胰腺神经内分泌瘤肝转移的Meta分析

Surgical resection for patients with the liver metastasis of gastroenteropancreatic neuroendocrine tumors： a Meta-analysis

目的 通过对胃肠胰腺神经内分泌瘤肝转移患者手术与非手术治疗对照研究的系统分析,探讨手术治疗胃肠胰腺神经内分泌瘤肝转移的价值.方法 检索Cochrane图书馆、PubMed、Medline、Embase、中国生物医学文献数据库、万方数据库中的相关随机研究,按照Cochrane推荐的文献纳入标准筛选文献,并对纳入文献进行质量评估,共有10组研究中心的1 567例患者的数据纳入进行Meta分析.结果 单纯手术切除治疗与药物（奥曲肽）治疗、全身放化疗、经动脉治疗、射频消融术等非手术治疗胃肠胰腺神经内分泌瘤肝转移相比较,3年生存率（OR：0.07,95％CI：0.02,0.22;Pheterogeneity=0.93,P＜0.00001）及5年生存率（OR：0.19,95％ CI：0.15,0.24;Pheterogeneity=0.11,P＜0.00001）差异具有统计学意义,手术治疗组的3、5年生存率明显优于非手术治疗组.结论 手术切除是治疗胃肠胰腺神经内分泌瘤肝转移的首选治疗方法,其安全有效且较其他非手术治疗在生存期方面具有较好的优势.

Objective To investigate the potential benefits of hepatic resection for patients with hepatic metastasis of gastroenteropancreatic neuroendocrine tumors.Methods A search in Cochrane Library,PubMed,Medline,Embase,CBM,Wanfang Databases for identifying randomized trails.Criteria for inclusion were established based on validity criteria by Cochrane Methods Group on screening and diagnostic tests,and correlated indexes of 10 articles including 1 567 patients were extracted for Meta-analysis.Results Compared with non-surgical treatment group,the 3-year survival rate （OR：0.07,95 % CI：0.02,0.22 ; Pheterogeneity =0.93,P 〈 0.00001）,the 5-year survival rate （OR：0.19,95 % CI：0.15,0.24 ; Pheterogeneity = 0.11,〈 0.00001） were significantly increased in the surgical group.Conclusions Surgical resection is the preferred treatment of gastroenteropancreatic neuroendocrine tumors in patients with liver metastasis.Surgery is safe and effective,furthermore it takes the advantages of significantly extend the surgical live time.